Blood Cell Development and Function Program, Fox Chase Cancer Center, 333 Burholme Avenue, Philadelphia, PA 19111, USA.
National Institute on Aging, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA.
Cell Rep. 2021 Feb 2;34(5):108716. doi: 10.1016/j.celrep.2021.108716.
TCF1 plays a critical role in T lineage commitment and the development of αβ lineage T cells, but its role in γδ T cell development remains poorly understood. Here, we reveal a regulatory axis where T cell receptor (TCR) signaling controls TCF1 expression through an E-protein-bound regulatory element in the Tcf7 locus, and this axis regulates both γδ T lineage commitment and effector fate. Indeed, the level of TCF1 expression plays an important role in setting the threshold for γδ T lineage commitment and modulates the ability of TCR signaling to influence effector fate adoption by γδ T lineage progenitors. This finding provides mechanistic insight into how TCR-mediated repression of E proteins promotes the development of γδ T cells and their adoption of the interleukin (IL)-17-producing effector fate. IL-17-producing γδ T cells have been implicated in cancer progression and in the pathogenesis of psoriasis and multiple sclerosis.
TCF1 在 T 细胞谱系的确定和 αβ 谱系 T 细胞的发育中起着关键作用,但它在 γδ T 细胞发育中的作用仍知之甚少。在这里,我们揭示了一个调控轴,其中 T 细胞受体 (TCR) 信号通过 Tcf7 基因座上的 E 蛋白结合调控元件来控制 TCF1 的表达,该轴调节 γδ T 细胞谱系的确定和效应器命运。事实上,TCF1 表达水平在设定 γδ T 细胞谱系确定的阈值方面起着重要作用,并调节 TCR 信号影响 γδ T 细胞谱系前体采用效应器命运的能力。这一发现为 TCR 介导的 E 蛋白抑制如何促进 γδ T 细胞的发育及其采用白细胞介素 (IL)-17 产生效应器命运提供了机制上的见解。产生 IL-17 的 γδ T 细胞已被牵涉到癌症的进展以及银屑病和多发性硬化症的发病机制中。